-transparent.png){kind=logo}
A selected group of 60 patients who had been resistant to previous systemic antibiotic therapy was treated with low-dose isotretinoin (0.5 mg/kg/day in two doses) for 12 to 20 weeks. The results confirmed the efficacy of the drug on pustular, nodular and cystic acne even with low-dose treatment. In only one case was it necessary to suspend the treatment because of an increase in serum cholesterol and triglycerides. The authors therefore advise the use of low dosage and that treatment should be restricted to cases of severe acne.
Related Publications
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
May 2012,
Acta dermato-venereologica,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
June 2019,
Cutis,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
January 2003,
International journal of clinical pharmacology research,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
January 2010,
Indian journal of dermatology, venereology and leprology,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
April 2006,
Journal of the American Academy of Dermatology,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
July 2010,
Medical journal, Armed Forces India,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
September 2011,
The British journal of dermatology,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
June 1996,
Lancet (London, England),
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
January 1985,
Canadian family physician Medecin de famille canadien,
M Bellosta, and
M Vignini, and
L Miori, and
G Rabbiosi
May 2014,
Indian journal of dermatology,
